Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy A Slivnick

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Plos One|November 18, 2022
Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonanceJeremy A Slivnick, Karolina M Zareba, Vien T Truong, et al.
The American Journal of Cardiology|April 22, 2018
Current Trends in Anticoagulation Bridging for Patients With Chronic Atrial Fibrillation on Warfarin Undergoing EndoscopyJeremy A Slivnick, Raymond Y Yeow, Colin McMahon, et al.
American Journal of Perinatology|December 2, 2021
Imaging-Based Risk Stratification for Recurrence Risk in Women with a History of Peripartum CardiomyopathyMarwan Ma'ayeh, Jeremy A Slivnick, Monique E McKiever, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 14, 2022
Three-Dimensional Echocardiographic Deconstruction: Feasibility of Clinical Evaluation from Two-Dimensional Views Derived from a Three-Dimensional Data SetMichael P Henry, Juan I Cotella, Jeremy A Slivnick, et al.
JACC. Cardiovascular Imaging|September 20, 2020
Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac AmyloidosisJeremy A Slivnick, Matthew S Tong, Haikady N Nagaraja, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 10, 2022
Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac AmyloidosisCristiane C Singulane, Jeremy A Slivnick, Karima Addetia, et al.
Echocardiography (Mount Kisco, N.Y.)|January 9, 2023
Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosisJuan I Cotella, Jeremy A Slivnick, Emily Sanderson, et al.
The International Journal of Cardiovascular Imaging|October 17, 2020
Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosisJeremy A Slivnick, Alexander L Wallner, Ajay Vallakati, et al.
The International Journal of Cardiovascular Imaging|January 4, 2026
Automated analysis of echocardiographic images: do different artificial intelligence tools provide concordant measurements?Teodora Szasz, Juan I Cotella, Jeremy A Slivnick, et al.
JACC. Cardiovascular Imaging|April 13, 2023
Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac AmyloidosisJung Woo Kwon, Aliya N Husain, Jeffrey Mueller, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Plos One|November 18, 2022
Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonanceJeremy A Slivnick, Karolina M Zareba, Vien T Truong, et al.
The American Journal of Cardiology|April 22, 2018
Current Trends in Anticoagulation Bridging for Patients With Chronic Atrial Fibrillation on Warfarin Undergoing EndoscopyJeremy A Slivnick, Raymond Y Yeow, Colin McMahon, et al.
American Journal of Perinatology|December 2, 2021
Imaging-Based Risk Stratification for Recurrence Risk in Women with a History of Peripartum CardiomyopathyMarwan Ma'ayeh, Jeremy A Slivnick, Monique E McKiever, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 14, 2022
Three-Dimensional Echocardiographic Deconstruction: Feasibility of Clinical Evaluation from Two-Dimensional Views Derived from a Three-Dimensional Data SetMichael P Henry, Juan I Cotella, Jeremy A Slivnick, et al.
JACC. Cardiovascular Imaging|September 20, 2020
Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac AmyloidosisJeremy A Slivnick, Matthew S Tong, Haikady N Nagaraja, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 10, 2022
Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac AmyloidosisCristiane C Singulane, Jeremy A Slivnick, Karima Addetia, et al.
Echocardiography (Mount Kisco, N.Y.)|January 9, 2023
Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosisJuan I Cotella, Jeremy A Slivnick, Emily Sanderson, et al.
The International Journal of Cardiovascular Imaging|October 17, 2020
Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosisJeremy A Slivnick, Alexander L Wallner, Ajay Vallakati, et al.
The International Journal of Cardiovascular Imaging|January 4, 2026
Automated analysis of echocardiographic images: do different artificial intelligence tools provide concordant measurements?Teodora Szasz, Juan I Cotella, Jeremy A Slivnick, et al.
JACC. Cardiovascular Imaging|April 13, 2023
Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac AmyloidosisJung Woo Kwon, Aliya N Husain, Jeffrey Mueller, et al.
Pageof 4